These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23979445)

  • 1. [Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].
    Bolenz C; Martini T; Michel MS
    Urologe A; 2013 Sep; 52(9):1242-7. PubMed ID: 23979445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
    Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
    Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
    Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay.
    Bolenz C; Gorzelanny C; Knauf D; Keil T; Steidler A; Halter N; Martini T; Schneider SW
    J Urol; 2013 May; 189(5):1939-44. PubMed ID: 23063805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
    van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
    Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
    Shariat SF; Youssef RF; Gupta A; Chade DC; Karakiewicz PI; Isbarn H; Jeldres C; Sagalowsky AI; Ashfaq R; Lotan Y
    J Urol; 2010 May; 183(5):1744-50. PubMed ID: 20299037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosis in muscle-invasive urothelial carcinoma of the bladder.
    He YD; Luo ZH; Yang M; Ruan XX; Liu SY; Wu ZQ; Deng WM; Shao CK; Su ZL; He D; Gao X; Li LY
    Biochem Biophys Res Commun; 2015 Apr; 459(3):416-23. PubMed ID: 25744029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
    Jimenez RE; Hussain M; Bianco FJ; Vaishampayan U; Tabazcka P; Sakr WA; Pontes JE; Wood DP; Grignon DJ
    Clin Cancer Res; 2001 Aug; 7(8):2440-7. PubMed ID: 11489824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.
    Wang L; Zhang Q; Wu P; Xiang W; Xie D; Wang N; Deng M; Cao K; Zeng H; Xu Z; Xiaoming Liu ; He L; Long Z; Tan J; Wang J; Liu B; Liu J
    Cancer Sci; 2020 Jul; 111(7):2349-2360. PubMed ID: 32449280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome?
    Oliva IV; Smith SL; Chen Z; Osunkoya AO
    Hum Pathol; 2011 Jan; 42(1):51-6. PubMed ID: 20870265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.
    Deng M; Wei W; Duan J; Chen R; Wang N; He L; Peng Y; Ma X; Wu Z; Liu J; Li Z; Zhang Z; Jiang L; Zhou F; Xie D
    Cancer Sci; 2021 May; 112(5):1758-1771. PubMed ID: 33440047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and systemic recurrence patterns of urothelial cancer after radical cystectomy.
    Ozbir S; Girgin C; Kara C; Dinçel C
    Kaohsiung J Med Sci; 2014 Oct; 30(10):504-9. PubMed ID: 25438681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
    Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
    Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.
    DeGraff DJ; Cates JM; Mauney JR; Clark PE; Matusik RJ; Adam RM
    Urol Oncol; 2013 Aug; 31(6):802-11. PubMed ID: 21924649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma.
    Nakagawa T; Kanai Y; Nakanishi H; Komiyama M; Fujimoto H
    Jpn J Clin Oncol; 2012 Nov; 42(11):1066-72. PubMed ID: 22914320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.